Cabot Corp (NYSE:CBT) – Equities researchers at Jefferies Group increased their FY2018 EPS estimates for shares of Cabot in a research report issued on Thursday. Jefferies Group analyst L. Alexander now expects that the specialty chemicals company will post earnings of $3.95 per share for the year, up from their previous forecast of $3.80. Jefferies Group currently has a “Buy” rating and a $78.00 target price on the stock. Jefferies Group also issued estimates for Cabot’s Q4 2018 earnings at $1.09 EPS.

Cabot (NYSE:CBT) last announced its earnings results on Tuesday, February 6th. The specialty chemicals company reported $0.93 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.15. Cabot had a net margin of 2.30% and a return on equity of 15.01%. The business had revenue of $720.00 million during the quarter, compared to the consensus estimate of $653.54 million. During the same quarter last year, the firm earned $0.84 earnings per share. Cabot’s quarterly revenue was up 17.8% on a year-over-year basis.

A number of other equities analysts also recently weighed in on the stock. Loop Capital raised shares of Cabot from a “hold” rating to a “buy” rating and set a $82.00 target price for the company in a research note on Friday, January 5th. Zacks Investment Research cut shares of Cabot from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th. KeyCorp restated a “hold” rating on shares of Cabot in a report on Wednesday, November 1st. SunTrust Banks upgraded shares of Cabot to a “buy” rating and set a $73.00 price target for the company in a report on Tuesday, January 16th. Finally, ValuEngine upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $70.33.

Cabot (NYSE CBT) opened at $62.15 on Friday. Cabot has a 52 week low of $50.21 and a 52 week high of $68.63. The firm has a market cap of $3,830.81, a price-to-earnings ratio of 63.42, a P/E/G ratio of 1.58 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.17 and a current ratio of 1.63.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 9th. Shareholders of record on Friday, February 23rd will be issued a $0.315 dividend. This represents a $1.26 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date of this dividend is Thursday, February 22nd. Cabot’s payout ratio is 128.57%.

A number of large investors have recently bought and sold shares of the business. Ameritas Investment Partners Inc. grew its holdings in Cabot by 2.0% in the second quarter. Ameritas Investment Partners Inc. now owns 18,696 shares of the specialty chemicals company’s stock worth $999,000 after purchasing an additional 363 shares during the period. Gratus Capital LLC grew its holdings in Cabot by 9.9% in the third quarter. Gratus Capital LLC now owns 8,853 shares of the specialty chemicals company’s stock worth $494,000 after purchasing an additional 800 shares during the period. American International Group Inc. grew its holdings in Cabot by 0.7% in the fourth quarter. American International Group Inc. now owns 128,162 shares of the specialty chemicals company’s stock worth $7,893,000 after purchasing an additional 855 shares during the period. Pacer Advisors Inc. grew its holdings in shares of Cabot by 11.5% during the third quarter. Pacer Advisors Inc. now owns 9,232 shares of the specialty chemicals company’s stock valued at $515,000 after buying an additional 950 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Cabot by 48.4% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,663 shares of the specialty chemicals company’s stock valued at $226,000 after buying an additional 1,194 shares during the last quarter. Institutional investors and hedge funds own 84.02% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “FY2018 EPS Estimates for Cabot Corp Increased by Analyst (CBT)” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://theolympiareport.com/2018/02/11/fy2018-eps-estimates-for-cabot-corp-increased-by-analyst-cbt.html.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.